H. R. 1942
IN THE HOUSE OF REPRESENTATIVES
April 22, 2015
Mr. Guinta (for himself, Ms. Schakowsky, Mr. Buchanan, Ms. Michelle Lujan Grisham of New Mexico, Mr. Whitfield, Mr. Conyers, Mr. Wilson of South Carolina, Mr. Grijalva, Mr. Lance, Ms. Eshoo, Mr. LoBiondo, Mr. Blumenauer, Mr. King of New York, Mr. Quigley, Mr. Gibson, Mrs. Lowey, Mr. Jones, Mr. Farr, Mr. Meehan, Ms. DeLauro, Ms. Ros-Lehtinen, Mr. Pallone, Mr. Smith of New Jersey, Mr. Gene Green of Texas, Mr. Marino, Mr. Serrano, Mr. Dent, Mr. Price of North Carolina, Ms. Stefanik, Ms. Roybal-Allard, Mr. Frelinghuysen, Mr. Fattah, Mr. Calvert, Ms. Lee, Mr. Harris, Ms. McCollum, Mr. Jolly, Ms. Wasserman Schultz, Mr. Fitzpatrick, Mr. Israel, Mr. Kilmer, and Mr. Ruppersberger) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Agriculture, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
To prevent human health threats posed by the consumption of equines raised in the United States.
This Act may be cited as the
Safeguard American Food Exports Act of 2015.
Congress finds that—
unlike cows, pigs, and other domesticated species, horses and other members of the equidae family are not raised for the purpose of human consumption;
equines raised in the United States are frequently treated with substances that are not approved for use in horses intended for human consumption and equine parts are therefore unsafe within the meaning of section 409 of the Federal Food, Drug, and Cosmetic Act;
equines raised in the United States are frequently treated with drugs, including phenylbutazone, acepromazine, boldenone undecylenate, omeprazole, ketoprofen, xylazine, hyaluronic acid, nitrofurazone, polysulfated glycosaminoglycan, clenbuterol, tolazoline, and ponazuril, which are not approved for use in horses intended for human consumption and equine parts are therefore unsafe within the meaning of section 512 of the Federal Food, Drug, and Cosmetic Act; and
consuming parts of an equine raised in the United States likely poses a serious threat to human health and the public should be protected from these unsafe products.
Section 301 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 331) is amended by adding at the end the following:
Notwithstanding any other provision of this section—
equine parts shall be deemed unsafe under section 409 of this Act;
equine parts shall be deemed unsafe under section 512 of this Act; and
the knowing sale or transport of equines or equine parts in interstate or foreign commerce for purposes of human consumption is hereby prohibited.